POS-524 MORTALITY AMONG NEW HAEMODIALYSIS PATIENTS IN THE FIRST SIX MONTHS OF COVID-19 PANDEMIC
Main Authors: | A. HAZARA, A. Lamplugh, X. Kassianides, S. Bhandari |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-04-01
|
Series: | Kidney International Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2468024921006987 |
Similar Items
-
Conversion of haemodialysis patients from iron sucrose to iron isomaltoside: a real-world experience
by: Jorge A. Jesus-Silva, et al.
Published: (2020-06-01) -
COVID-19 in haemodialysis patients: result analysis of the first year of the pandemic
by: Mikhail L. Zubkin, et al.
Published: (2021-11-01) -
The Impact of Intravenous Iron on Renal Injury and Function Markers in Patients With Chronic Kidney Disease and Iron Deficiency Without Anemia
by: Xenophon Kassianides, et al.
Published: (2022-02-01) -
POS-800 DROXIDOPA FOR MANAGEMENT OF CHRONIC HYPOTENSION IN HAEMODIALYSIS
by: A. Jayanti, et al.
Published: (2021-04-01) -
Morbidity and mortality on chronic haemodialysis
by: C Praehauser, et al.
Published: (2011-01-01)